Literature DB >> 2859042

A class experiment in clinical pharmacology using beta-adrenoceptor antagonist drugs.

C R Kumana, C W Ogle.   

Abstract

Cardiac beta-adrenoceptor blocking activity was evaluated in a between-subject study carried out as a class experiment with pre-clinical medical students participating in a practical pharmacology course. From each of 10 groups of students, three healthy male volunteers, took oral propranolol 80 mg, pindolol 10 mg or placebo, according to a double-blind randomised protocol. Pre-treatment, and 45-60 min (1 h) and 105-120 min (2 h) post-treatment heart rate (HR) was determined electrocardiographically in the last 15 s during periods of rest (sitting for 5 min), isometric exercise (applying a standardized hand grip to a rolled sphygmomanometer cuff to elevate pressure from 50 to 150 mm Hg; 2 min) and dynamic exercise (bicycle ergometry with a load of 150 W for 3 min). Reductions from pre-treatment HR yielded statistically significant differences during exercise (isometric and dynamic) between all corresponding changes on placebo and active drugs (P less than 0.05-0.01), except with the 1 h post-propranolol hand grip HR. At rest, only the difference between 2 h HR changes on placebo and propranolol achieved statistical significance (P = 0.05); presumably, the partial agonist activity of pindolol overcame any minimal HR slowing liable to occur at rest. Cardiac beta-adrenoceptor blocking activity as judged by reductions in HR from pretreatment values, was more evident during cycling than during hand grip; and during hand grip than at rest.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859042      PMCID: PMC1463721          DOI: 10.1111/j.1365-2125.1985.tb02628.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  3 in total

1.  Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man.

Authors:  S Epstein; B F Robinson; R L Kahler; E Braunwald
Journal:  J Clin Invest       Date:  1965-11       Impact factor: 14.808

Review 2.  Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

3.  Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.

Authors:  J D Fitzgerald; S R O'Donnell
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.